Cerus Newswire

Cerus Newswire

Comprehensive Real-Time News Feed for Cerus.

Results 1 - 20 of 213 in Cerus

  1. Cerus Co. (NASDAQ:CERS) Given Consensus Rating of "Buy" by AnalystsRead the original story w/Photo

    Yesterday | Daily Political

    Cerus Co. has earned a consensus recommendation of "Buy" from the nine ratings firms that are currently covering the company.

    Comment?

  2. Cerus' (CERS) Outperform Rating Reaffirmed at Robert W. BairdRead the original story w/Photo

    Wednesday | AmericanBankingNews.com

    ... CERS. BTIG Research reiterated a "buy" rating and issued a $10.00 price target (up previously from $8.00) on shares of Cerus in a research note on Friday, April 22nd. FBR & Co. reiterated a "buy" rating on shares of Cerus in a research note on ...

    Comment?

  3. Cellular Dynamics Appoints Derek Hei, Ph.D., as Vice President of...Read the original story w/Photo

    Tuesday Jun 21 | PR Newswire

    ... for government funded cell banking and cell therapy development programs and has professional industry experience at Cerus Corporation and Genentech. , Ph.D., CDI President and Chief Operating Officer , said, "CDI has always had the goal of being ...

    Comment?

  4. Cerus Co. (CERS) Stock Rating Reaffirmed by BTIG ResearchRead the original story w/Photo

    Monday Jun 20 | Daily Political

    ... stock. BTIG Research's target price suggests a potential upside of 62.87% from the company's previous close. Shares of Cerus (NASDAQ:CERS) traded up 7.72% during mid-day trading on Monday, reaching $6.14. 3,393,617 shares of the company's stock ...

    Comment?

  5. BTIG Research Reiterates Buy Rating for Cerus Co.Read the original story w/Photo

    Monday Jun 20 | AmericanBankingNews.com

    ... have recently modified their holdings of the stock. Legal & General Group Plc increased its position in shares of Cerus by 11.0% in the first quarter. Legal & General Group Plc now owns 17,612 shares of the company's stock valued at $105,000 after ...

    Comment?

  6. HHS reaches deals to target spread of ZikaRead the original story w/Photo

    Monday Jun 20 | Washington Examiner

    The Obama administration is moving to reduce the spread of the Zika virus and other diseases through blood transfusions, the Department of Health and Human Services announced Monday. A California company, Cerus Corp., will conduct clinical trials of its Intercept system under a three-year, $30.8 million agreement with HHS.

    Comment?

  7. Cerus Corporation is Surging Today. Here's Why.Read the original story w/Photo

    Monday Jun 20 | The Motley Fool

    ... calls for BARDA, which is part of the U.S. Department of Health and Human Services, to provide financial support to Cerus so it can continue to develop its Intercept Blood System. This funding will be used primarily to support continued clinical ...

    Comment?

  8. Cerus Announces Agreement With For Potential Funding Of Up To...Read the original story

    Sunday Jun 19 | BioSpace

    Cerus Corporation , a biomedical products company focused on improving blood transfusion safety, today announced an agreement with the Biomedical Advanced Research and Development Authority , part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, to support Cerus' clinical development program for pathogen reduction of red blood cell components, including access to funding that could support various activities, including funding studies necessary to support an FDA submission and accelerate commercial scale up to facilitate potential adoption by U.S. blood centers.

    Comment?

  9. 10 Biggest Mid-Day Gainers For MondayRead the original story

    Monday Jun 20 | Benzinga

    ... positive results for Reducer system treatment for refractory angina were published in The Netherlands Heart Journal. Cerus Corporation (NASDAQ: CERS ) shares gained 8.77 percent to $6.20 as the company announced an agreement Sunday with the BARDA ...

    Comment?

  10. Why Anthem, Cigna, Fiat Chrysler, and Two Other Stocks Are Trending TodayRead the original story w/Photo

    Monday Jun 20 | Insider Monkey

    ... today are Anthem Inc (NYSE: ANTM ) , CIGNA Corporation (NYSE: CI ) , Fiat Chrysler Automobiles NV (NYSE: FCAU ) , Cerus Corporation (NASDAQ: CERS ) , and Six Flags Entertainment Corp (NYSE: SIX ). Let's find out why traders are buzzing about these ...

    Comment?

  11. 12 Stocks Moving In Monday's Pre-Market SessionRead the original story

    Monday Jun 20 | Benzinga

    ... rose 27.98 percent to $2.15 in pre-market trading as the company reported the FDA Fast Track designation for ProTmune. Cerus Corporation (NASDAQ: CERS ) shares rose 13.16 percent to $6.45 in pre-market trading as the company announced an agreement ...

    Comment?

  12. Cerus Announces Agreement with BARDA for Potential Funding of up to...Read the original story

    Sunday Jun 19 | PressReleasePoint

    Cerus Announces Agreement with BARDA for Potential Funding of up to approximately $180 million to Advance its INTERCEPT Red Blood Cell Program CONCORD, CA -- -- June 19, 2016 -- Cerus Corporation , a biomedical products company focused on improving blood transfusion safety, today announced an agreement with the Biomedical Advanced Research and Development Authority , part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, to support Cerus' clinical development program for pathogen reduction of red blood cell components, including access to funding that could support various activities, including funding studies necessary to support an FDA submission and accelerate commercial scale up to facilitate potential adoption by U.S. blood centers.

    Comment?

  13. Cerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180...Read the original story w/Photo

    Sunday Jun 19 | Freshnews

    Cerus Corporation , a biomedical products company focused on improving blood transfusion safety, today announced an agreement with the Biomedical Advanced Research and Development Authority , part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, to support Cerus' clinical development program for pathogen reduction of red blood cell components, including access to funding that could support various activities, including funding studies necessary to support an FDA submission and accelerate commercial scale up to facilitate potential adoption by U.S. blood centers.

    Comment?

  14. The Probable Reason Behind Cerus Corp's 11.2% Drop in MayRead the original story w/Photo

    Thursday Jun 9 | Fox News

    What: Shareholders of Cerus Corp , a biomedical products company focused on blood transfusion,had a rough month. The company's stock shed more than 11% of its value during May, according to data from S&P Global Market Intelligence .That's quite a big move downward, especially during a time frame when the healthcare sector in general did well.

    Comment?

  15. Cerus Co. (CERS) Rating Reiterated by FBR & Co.Read the original story w/Photo

    Sunday Jun 5 | AmericanBankingNews.com

    ... stock had its "buy" rating reiterated by equities researchers at FBR & Co. in a note issued to investors on Wednesday. Cerus (NASDAQ:CERS) traded down 2.99% during midday trading on Wednesday, hitting $5.52. 603,275 shares of the company traded ...

    Comment?

  16. Cerus: Will It Ever Get Respect?Read the original story w/Photo

    Wednesday Jun 1 | Seeking Alpha

    It can happen to anyone and anything including publicly traded companies that appear to be firing on all cylinders. Case in point is Cerus Corporation, the Concord, California,-based bio-medical products company.

    Comment?

  17. Showpad Helps Cerus Corporation Share Vital Information During Zika EpidemicRead the original story

    Wednesday Jun 1 | Information Technology

    Cerus is able to leverage the Showpad platform quickly and efficiently to share vital medical information with its field sales organization. Cerus' INTERCEPT Blood System is designed to reduce the risk of transfusion transmitted infections by inactivating a broad range of pathogens, such as viruses, bacteria and parasites that may be present in donated blood.

    Comment?

  18. Cerus Co. (CERS) Position Boosted by UBS Asset Management Americas Inc.Read the original story w/Photo

    Wednesday Jun 1 | Daily Political

    UBS Asset Management Americas Inc. boosted its position in shares of Cerus Co. by 56.7% during the first quarter, Holdings Channel reports.

    Comment?

  19. Cerus Co. (NASDAQ:CERS) Receives $8.70 Average Price Target from AnalystsRead the original story w/Photo

    Wednesday Jun 1 | Daily Political

    Cerus Co. has been given an average recommendation of "Buy" by the nine analysts that are covering the firm.

    Comment?

  20. Granite Investment Partners LLC Invests $1,331,000 in Cerus Co.Read the original story w/Photo

    Tuesday May 31 | Daily Political

    Granite Investment Partners LLC purchased a new position in shares of Cerus Co. during the first quarter, Holdings Channel reports.

    Comment?